Dream Luminator
Lv2
120 积分
2021-12-29 加入
-
Recent advances in understanding the molecular role of phosphoinositide-specific phospholipase C gamma 1 as an emerging onco-driver and novel therapeutic target in human carcinogenesis
20小时前
已完结
-
Protein tyrosine phosphatase PTPN22 has dual roles in promoting pathogen versus homeostatic-driven CD8 T-cell responses
15天前
已完结
-
Deciphering autoimmune susceptibility: a meta-analysis of PTPN22 gene variants
15天前
已完结
-
Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trial
16天前
已完结
-
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype
17天前
已完结
-
Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials
17天前
已完结
-
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
17天前
已完结
-
Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE
17天前
已完结
-
Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps
18天前
已完结
-
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial
18天前
已完结